Pancreatic Cancer Research

ResearcherRenJi HospitalActive in the last 2 years

Liwei Wang

Provisional: name at one institution (moderate confidence)As of 11 November 2026

Known by name at one institution; no external author ID yet. Name as it appears in ClinicalTrials.gov.

Their work

Papers
0
Trials
3 (principal investigator on 3)
Grants
0
Collaborators
0
Papers, trials and grants by year

2017: 1 trial · 2018: none · 2019: 1 trial · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 trial

Trials 3

  1. Anlotinib Plus Benmelstobart and AG in First-line Treatment of Advanced Metastatic Pancreatic Cancer (ALTER-PA-001) Principal investigator NCT06621095↗
  2. SHR- 1210 Combined With Paclitaxel (Albumin Bound) and Gemcitabine as First-line Therapy in Patients With Metastatic Pancreatic Cancer Principal investigator NCT04181645↗
  3. An Open-label, Multicenter, Prospective Study of Irreversible Electroporation (Nano Knife) Combined With Radiotherapy and Chemotherapy in Patients With Locally… Principal investigator NCT04310553↗

Closest collaborators

No collaborators recorded.

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.